SVB Leerink Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Market Perform
SVB Leerink lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a market perform rating in a research note published on Tuesday, Marketbeat reports. SVB Leerink currently has $15.00 price target on the stock. Several other research firms have also recently weighed in on ZNTL. Wedbush restated an outperform rating […]
More Stories
Why Americans Pay High Gas Prices Despite Record U.S. Oil Production and Exports
By Stephen Zogopoulos, USNN World News The Paradox at the Pump As of early May 2026, U.S. regular gasoline prices...
What Time Does Netflix Release Shows? Don’t Miss Another New Release
Many of us like to watch series and movies, but most of the time miss the new release, right? And...
Trump Calls Iran’s Response to Peace Proposal ‘Totally Unacceptable’
By Tom Gantert U.S. President Donald Trump on May 10 rejected Iran’s response to the latest peace proposal pitched by...
Iran Turns to China Rail Link to Bypass US Blockade, but It Has Limited Effect, Analysts Say
By Alex Wu As the U.S. military continues to blockade Iranian ports, Iran has increased overland railway shipment with China...
Passengers Evacuate Cruise Ship Hit by Deadly Hantavirus Outbreak
By Tom Gantert The passengers and crew aboard the MV Hondius exited the hantavirus-stricken cruise ship in the Canary Islands...
Hantavirus Symptoms Reported on Cruise Evacuation Flight
By Tom Gantert A French citizen on the MV Hondius cruise ship came down with hantavirus symptoms while flying back...